Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
RENOIR
Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients
- NCT02390869 ↗
- Active, not recruiting
- Fondazione Italiana Linfomi - ETS
- Focused
We haven't built an HCP commentary report on RENOIR (lenalidomide plus rituximab in relapsed/refractory follicular lymphoma) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on RENOIR so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 3 | |
| YouTube | 2 | |
| Podcasts | 2 |
The trial
ClinicalTrials.gov- Official title
- A Randomized Phase III Multicenter Trial Assessing Efficacy and Toxicity of a Combination of Rituximab and Lenalidomide (R2) vs Rituximab Alone as Maintenance After Chemoimmunotherapy With Rituximab-chemotherapy (R-CHT) for Relapsed/Refractory FL Patients Not Eligible for Autologous Transplantation (ASCT).
- Phase
- Phase 3
- Status
- Active, not recruiting
- Conditions
- Lymphoma, Follicular
- Interventions
- R2-MANT; R-MANT
- Arms
- R2-MANT · Experimental
- R-MANT · Active comparator
- Enrollment
- 128
- Primary outcomes
- PFS
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Start
- May 2014
- Primary completion
- Jan 25, 2023
- Results posted
- No
- Registry record
- NCT02390869 · updated Aug 19, 2026
Publications
linked from the registry- Botto B, Boccomini C, Evangelista A, Zilioli VR, Anastasia A, Cavallo F, Merli F, Zanni M, Tani M, Chiarenza A, Liberati AM, Conconi A, Rusconi C, Bari A, Del Giudice I, Gaidano G, Spina M, Maschio N, Castellino C, Rota-Scalabrini D, Puccini B, Arcari A, Bigliardi S, Matta GME, Bianchi B, Mannina D, Marino D, Galieni P, Ciambelli F, Musuraca G, Muzi C, Bottelli C, Genuardi E, Meli E, Ferrero S, Luminari S, Ladetto M, Ciccone G, Vitolo U. Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma. Blood Adv. 2026 Jun 25:bloodadvances.2025018732. doi: 10.1182/bloodadvances.2025018732. Online ahead of print. PubMed 42349017